Class II — Potential Health Hazard

Potential health hazard — use of or exposure to this product may cause temporary or medically reversible adverse health consequences.

ZYMUTEST HIA MonoStria qualitative screening assay intended for the global Recalled by Hyphen BioMed Due to Incorrect package insert indicating use of the kits...

Date: February 5, 2018
Company: Hyphen BioMed
Status: Terminated
Source: FDA (Device)

What You Should Do

Stop using this product immediately. Do not consume, use, or distribute it.

Return the product to the place of purchase for a full refund. If you have questions, contact Hyphen BioMed directly.

Affected Products

ZYMUTEST HIA MonoStria qualitative screening assay intended for the global detection of heparin-dependent antibodies, whether the isotype is: IgG, IgM and IgA, in human plasma, by clinical laboratories. p IgGAM; REF Number: RK041D; UDI: 03663537046810

Quantity: 60

Why Was This Recalled?

Incorrect package insert indicating use of the kits with plasma, serum, and other biological fluids. The kits should only be used with plasma.

Where Was This Sold?

This product was distributed to 5 states: MD, NH, NY, NC, OH

Affected (5 states)Not affected

About Hyphen BioMed

Hyphen BioMed has 5 total recalls tracked by RecallDetector.

Related Recalls

Data sourced from the FDA (Device). Last updated March 26, 2026. View original report